Applied dna secures blanket purchase order for 10,000 linea™ covid-19 tests

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that it has secured a blanket purchase order from an existing customer for its linea™ covid-19 assay kit (the “assay kit”) and consumables to conduct 10,000 tests. the company has already shipped a portion of the purchase order in the current fiscal quarter ending december 31, 2020. the balance of the
APDN Ratings Summary
APDN Quant Ranking